Difficulty: Medium
Average Score: 72%
Practice
Indication of cyclosporine A is:
Correct answer
D
Rationale
In the context of Lifespan Pharmacology, understanding the indications for medications like cyclosporine A is crucial for providing safe and effective patient care. The correct answer, D) Idiopathic nephrotic syndrome, is supported by the pharmacological action of cyclosporine A.
Cyclosporine A is an immunosuppressant drug that works by inhibiting T-cell activation. In the case of idiopathic nephrotic syndrome, which is characterized by excessive protein excretion in urine due to kidney damage from immune system dysfunction, cyclosporine A can help by suppressing the immune response and reducing kidney inflammation, thereby improving renal function.
Regarding why the other options are incorrect:
A) Secondary immunodeficiency: Cyclosporine A is not typically indicated for secondary immunodeficiency conditions as it works by suppressing the immune system, which could exacerbate the immunodeficiency.
B) Hairy cell leukemia: Cyclosporine A is not a standard treatment for leukemia, especially hairy cell leukemia, as it does not target the underlying cancerous cells in this context.
C) Primary immunodeficiency: Similar to secondary immunodeficiency, using an immunosuppressant like cyclosporine A in primary immunodeficiency would further compromise the immune system, making it an inappropriate treatment option.
By understanding the specific indications of cyclosporine A, healthcare providers can make informed decisions about its use, ensuring optimal patient outcomes. This question reinforces the importance of pharmacological knowledge and critical thinking in selecting appropriate drug therapies based on the underlying pathophysiology of the condition being treated.
Cyclosporine A is an immunosuppressant drug that works by inhibiting T-cell activation. In the case of idiopathic nephrotic syndrome, which is characterized by excessive protein excretion in urine due to kidney damage from immune system dysfunction, cyclosporine A can help by suppressing the immune response and reducing kidney inflammation, thereby improving renal function.
Regarding why the other options are incorrect:
A) Secondary immunodeficiency: Cyclosporine A is not typically indicated for secondary immunodeficiency conditions as it works by suppressing the immune system, which could exacerbate the immunodeficiency.
B) Hairy cell leukemia: Cyclosporine A is not a standard treatment for leukemia, especially hairy cell leukemia, as it does not target the underlying cancerous cells in this context.
C) Primary immunodeficiency: Similar to secondary immunodeficiency, using an immunosuppressant like cyclosporine A in primary immunodeficiency would further compromise the immune system, making it an inappropriate treatment option.
By understanding the specific indications of cyclosporine A, healthcare providers can make informed decisions about its use, ensuring optimal patient outcomes. This question reinforces the importance of pharmacological knowledge and critical thinking in selecting appropriate drug therapies based on the underlying pathophysiology of the condition being treated.